Carl Zeiss Meditec AG ADR (CZMWY)

Currency in USD
60.11
-0.26(-0.43%)
Closed·
CZMWY Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 11 days
Fair Value
Day's Range
59.0760.11
52 wk Range
46.1380.09
Key Statistics
Prev. Close
60.36
Open
59.28
Day's Range
59.07-60.11
52 wk Range
46.13-80.09
Volume
1.44K
Average Volume (3m)
1.53K
1-Year Change
-10.18%
Book Value / Share
25.66
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CZMWY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Carl Zeiss Meditec AG ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Carl Zeiss Meditec AG ADR Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics, as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Compare CZMWY to Peers and Sector

Metrics to compare
CZMWY
Peers
Sector
Relationship
P/E Ratio
28.7x13.2x−0.5x
PEG Ratio
−0.730.050.00
Price/Book
2.2x2.6x2.6x
Price / LTM Sales
2.1x2.0x3.2x
Upside (Analyst Target)
-50.8%41.4%
Fair Value Upside
Unlock18.3%6.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.77%
Dividend Yield
0.68%
Industry Median 1.34%
Annualised payout
0.41
Paid unevenly
5-Years Growth
-1.59%
Growth Streak

Earnings

Latest Release
May 13, 2025
EPS / Forecast
0.5805 / 0.4319
Revenue / Forecast
625.12M / 551.40M
EPS Revisions
Last 90 days

CZMWY Income Statement

FAQ

What Stock Exchange Does Carl Zeiss Meditec ADR Trade On?

Carl Zeiss Meditec ADR is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Carl Zeiss Meditec ADR?

The stock symbol for Carl Zeiss Meditec ADR is "CZMWY."

What Is the Carl Zeiss Meditec ADR Market Cap?

As of today, Carl Zeiss Meditec ADR market cap is 5.25B.

What Is Carl Zeiss Meditec ADR's Earnings Per Share (TTM)?

The Carl Zeiss Meditec ADR EPS (TTM) is 1.77.

When Is the Next Carl Zeiss Meditec ADR Earnings Date?

Carl Zeiss Meditec ADR will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is CZMWY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Carl Zeiss Meditec ADR Stock Split?

Carl Zeiss Meditec ADR has split 0 times.

How Many Employees Does Carl Zeiss Meditec ADR Have?

Carl Zeiss Meditec ADR has 5713 employees.

What is the current trading status of Carl Zeiss Meditec ADR (CZMWY)?

As of 27 Jul 2025, Carl Zeiss Meditec ADR (CZMWY) is trading at a price of 60.11, with a previous close of 60.36. The stock has fluctuated within a day range of 59.07 to 60.11, while its 52-week range spans from 46.13 to 80.09.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.